[值得知道的东西关于基于药物的骨质保护在泌尿瘤学]
Christian Thomas1, Martin Baunacke2
1Klinik und Poliklinik für Urologie, Universitätsklinikum Carl Gustav Carus Dresden an der Technischen Universität Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland. Christian.Thomas@uniklinikum-dresden.de.
Urologie (Heidelberg, Germany)
|February 20, 2025
概括
泌尿瘤学中的骨转移导致骨相关事件 (SREs),增加死亡风险. 骨质保护药物,如佐列龙酸和德诺苏马布,有助于预防SRE,但需要仔细监测与药物相关的下巴骨硬化 (MRONJ).
科学领域:
- 尿瘤学 尿瘤学
- 在瘤学瘤学.
- 骨转移管理 骨转移管理
背景情况:
- 泌尿瘤学中的骨转移显著提高了骨相关事件 (SREs) 的风险.
- 严重性脊髓损伤,特别是病理性骨折,与死亡率增加和治疗成本增加有关.
- 前列腺和细胞癌是晚期骨转移的常见原因.
研究的目的:
- 审查骨质保护药物在治疗尿瘤恶性瘤骨转移中的作用.
- 为了比较zoledronic acid和denosumab的疗效和使用情况.
- 要突出与长期治疗相关的与药物相关的下骨硬化 (MRONJ) 的风险.
主要方法:
- 关于尿瘤学骨转移的当前文献的综述.
- 对已批准的骨质保护药物的分析:佐列龙酸和denosumab.
- 药物管理,疗效和副作用的讨论,包括MRONJ.
主要成果:
- 佐莱德龙酸和德诺苏马布已被批准用于预防或延迟转移性疾病中的SRE.
- 在降低SREs的zoledronic酸有效性是有限的,在荷尔蒙敏感的前列腺癌.
- 长期使用这些药物需要定期监测口腔,因为MRONJ的风险.
结论:
- 骨保护药物对于管理骨转移至关重要,但需要量身定制的方法.
- 仔细的患者选择和监测对于减轻像MRONJ这样的风险至关重要.
- 进一步的研究可能会澄清在特定的泌尿瘤癌症中最佳的药物使用.
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Drug Distribution: Tissue Binding
2.5K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.5K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


